Mary Ann DeGroote

Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection

Maurizio Renna, Catherine Schaffner, Karen Brown et al. · Journal of Clinical Investigation · 2011 · 307 citations · Full text

Inflammatory Lung Disease, Microbial Pathogens, Azithromycin Blocks +23

Virulent<i>Salmonella typhimurium</i>has two periplasmic Cu, Zn-superoxide dismutases

Ferric C. Fang, Mary Ann DeGroote, John W. Foster et al. · Proceedings of the National Academy of Sciences · 1999 · 228 citations · Full text

Preclinical testing of new drugs for tuberculosis: current challenges

Anne J. Lenaerts, Mary Ann DeGroote, Ian M. Orme · Trends in Microbiology · 2008 · 86 citations

Pulmonary Tuberculosis, Preclinical Drug Evaluation, Tuberculosis Prevention +9

A metabolic biosignature of early response to anti-tuberculosis treatment

Sebabrata Mahapatra, Ann M. Hess, John L. Johnson et al. · BMC Infectious Diseases · 2014 · 71 citations · Full text

Treatment of Non-Tuberculous Mycobacterial Lung Disease

Julie V. Philley, Mary Ann DeGroote, Jennifer R. Honda et al. · Current treatment options in infectious diseases/Current treatment options in infectious disease · 2016 · 56 citations · Full text

Pulmonary Tuberculosis, Respiratory Infection, Tuberculosis +4